bioAffinity Technologies gets Japan patent allowance for CyPath Lung AI

bioAffinity Technologies said Japan issued a Notice of Allowance for a patent covering its noninvasive CyPath Lung test and AI-built algorithm for early-stage lung cancer detection, with issuance expected after payment of the fee.